Opioid therapy in addicted patients: Background and perspective from the US

Clinical Ethics in Anesthesiology: A Case-Based Textbook

Volumn , Issue , 2010, Pages 154-160

  Ballantyne, Jane C ^a   Klein, Joseph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927028904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511841361.028     Document Type: Chapter

References (18)

1. Webb et al. v United States, 249 US 96 (1919).
2. Horder, T.J. (1955). Manufacture of Heroin. The Times, London. 26th May;11e.
3. Webb-Johnson, A.E. House of Lords debates, 13th December 1955, vol 195, columns 45-6
4. Leech, K. (1991). The London Drug Scene in the 1960s. Policing and Prescribing, eds. Whynes D and Bean P. McMillan, London UK, pp. 43-4.
5. Zacny, J., Bigelow, G., Compton, P., et al. (2003). College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend, 69(3), 215-32.
6. Office of Applied Studies (2008). Results from the 2007 National Survey on Drug Use and Health: National findings DHHS Publication No. SMA 08-4343, NSDUH Series H-34. Rockville, MD: Substance Abuse and Mental Health Services Administration.
7. Van Zee A. (2009). The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health, 99(2), 221-7.
8. Kuehn, B.M. (2007). Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA, 17(3), 249.
9. Spence, D. (2010) Bad medicine: pain. Br Med J, 340, b5683.
10. Romanow, K. (2003). Criminal law: physician convicted for recklessly prescribing OxyContin. J Law Med Ethics, 31(1), 154-5.
11. Bergman v. Eden Medical Center, No. H205732-1 (Cal. Super. Ct. Aug. 20, 2001).
12. The Shipman Inquiry. http://www.the-shipmaninquiry.org.uk/home.asp.
13. Department of Health (2006). Safer Management of Controlled Drugs (CDs): Private CD prescriptions and other changes to the prescribing and dispensing of controlled drugs (CDs). Guidance for Implementations. Gateway Reference: 6820.
14. Eriksen, J., Sjogren, P., Bruera, E., et al. (2006). Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain, 125, 172-9.
15. Ballantyne, J.C. and Fleisher, L.A. (2010). Ethical issues in opioid prescribing for chronic pain. Pain, 148(3), 365-7.
16. Ballantyne, J.C. and LaForge, S.L. (2007). Opioid dependence and addiction in opioid treated pain patients. Pain, 129, 235-55.
17. Dubois, M.Y. (2005). The birth of an ethics charter for pain medicine. Pain Med, 6(3), 201-2.
18. Rubin, S.B. (2007). If we think it’s futile, can’t we just say no? HEC Forum, 19(1), 45-65.